Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24324253 | 0.86 | DPP4 (0.55) | DPP4 | |
| SCHEMBL24322510 | 0.86 | DPP4 (0.55) | DPP4 | |
| SCHEMBL24322567 | 0.80 | DPP4 (0.52) | DPP4 | |
| SCHEMBL6608701 | 0.77 | DPP7 (0.45) | DPP4 | |
| SCHEMBL6608698 | 0.77 | DPP7 (0.45) | DPP4 | |
| SCHEMBL11551371 | 0.77 | DPP7 (0.41) | DPP4 | |
| Hydrochloric Acid SCHEMBL6543701 | 0.76 | DPP7 (0.44) | DPP4 | |
| Hydrochloric Acid SCHEMBL6543703 | 0.76 | DPP7 (0.44) | DPP4 | |
| SCHEMBL16361285 | 0.75 | EPHX2 (0.44) | DPP4 | |
| SCHEMBL26039093 | 0.72 | DPP4 (0.51) | DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220122691-A1 | HtrA Inhibitors and CagA Inhibitors and Use Thereof | Psomagen Inc. (US) | 2022-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220122691-A1 | HtrA Inhibitors and CagA Inhibitors and Use Thereof | HTRA1, GIPR, HPN | DPP4 532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.